The purpose of this research is to introduce and validate novel sub-THz resonance spectroscopy combined with molecular dynamics (MD) computation as a promising approach for optical analysis and potential quantification of molecular biomarkers in ovarian (OC) cancer cells. The ability of sub-THz spectroscopy to identify and quantify biological molecules is demonstrated by interrogation of resonance features caused by atomic vibrations within biological molecules in cancer and normal samples. In vitro human cell cultures of two ovarian cancer subtypes, SK-OV-3 human epithelial and ES-2 human clear cell carcinoma, were characterized in comparison with a normal nontransformed cell line (FT131-human fallopian tube epithelial cell line). A dramatic difference between the THz absorption spectra of cancer and normal cells and cell free samples is observed with much higher absorption intensity and a strong absorption peak at frequency of ~13 cm −1 dominating the spectra from cancer samples. Comparison of experimental spectra with MD predictions of spectroscopic signatures of microRNA molecules from the miR-200 family, known to be overexpressed in ovarian cancer, suggests an origin for this pronounced spectral peak. The rest of the cancer samples' signature is in part similar to the signatures of normal cells and represents contributions from proteins and nucleic acid polymer molecules. Even though ovarian cancer is utilized for this proof of concept, the sub-THz spectroscopy method is very general and can be as well applied to other cancer types. PAPER RECEIVED
Introduction
Epithelial ovarian cancer is the most lethal female reproductive malignancy. Ovarian cancer is a devastating illness in which only 20% of patients are diagnosed with early stage I disease (Cannistra 2004) . The main reasons are lack of minimally invasive, early detection tests, subtle symptom development and tumor chemo-resistance. Currently, early detection interventions include serum measurement of protein biomarkers (e.g. CA-125, HE4, OVA1 ™ ) and ultrasound imaging. However, recently a randomized controlled trial of over 78,000 women demonstrated the lack of sensitivity and specificity, and overall benefit of this approach (Buys et al 2011) with a documented sensitivity of serum protein biomarker CA-125 for early stage disease of only 40% (Jacobs and Menon 2004) .
In addition, only 10-15% of patients will remain in prolonged remission after initial cytotoxic therapy (Olivier et al 2006) . At the same time, ovarian cancer is highly curable if detected early (85% survival for stage I disease) (Sturgeon et al 2008) . Thus, development of novel approaches for overcoming the limitations for detection of early stage disease and identification of stable biomarkers, which can be routinely measured in easily accessible samples, remains a high priority area of investigation in gynecological oncology.
Human serum and other body fluids are rich resources for the identification of novel biomarkers, which can be measured in routine clinical diagnosis. Over many decades it has been shown that cell-free DNA and RNA are present in serum and other body fluids and that these circulating nucleic acids may represent potential biomarkers (Swarup and Rajeswari 2007, Sub-terahertz vibrational spectroscopy for microRNA based diagnostic of ovarian cancer Tsang and Lo 2007 , Diehl et al 2008 , Brase et al 2010 . Recent advances in sequencing technologies have led to an increased focus on blood-derived nucleic acid-based approaches for biomarker discovery. Investigations of differences between normal and malignant cells have revealed alterations in DNA, proteins and associated mRNA changes, as well as deregulated noncoding RNA expression (Diehl et al 2008) . Many of these differences have been shown to be detectable in the blood stream. Therefore, there is strong rationale for taking advantage of increasingly available sequencing modalities for blood-derived biomarker discovery.
A decade ago, microRNAs were discovered as a novel class of evolutionarily conserved small (18-24 bp nucleotides) non-coding RNA molecules, which are important regulators of gene expression (Ambros 2004 , Bartel 2004 , Brase et al 2010 . Hundreds of microRNAs have been found in various organisms, suggesting their potential roles in all biological events (Bartel and Chen 2004 , Felli et al 2005 , Rosa et al 2007 . Expression levels of microRNAs can distinguish malignant and nonmalignant ovarian epithelium. A number of publications in medical literature (see references below) suggested that the use of microRNA as a biomarker for disease might be useful, particularly for cancer detection. First, the potential to extract and reliably determine cellfree microRNAs in body fluids like serum was shown in Lawrie et al (2008) . This makes it possible to evaluate biomarkers using less invasive procedures such as blood draws rather than the need for biopsies, and could potentially be used to detect disease at an earlier stage in individuals genetically prone to a par ticular cancer. Second, cell-free microRNAs in body fluids were found to be stable under harsh conditions including boiling, low/high pH, extended storage and multiple freeze-thaw cycles (Chen et al 2008 , Mitchell et al 2008 , Gilad et al 2008 , Taylor and Gercel-Taylor 2008 , Ho et al 2010 . It has been reported that serum and other body fluids contain sufficiently stable microRNA signatures. A good correlation was observed when the individual microRNA levels were compared between serum and plasma samples from the same patient donors (Mitchell et al 2008) , thus, both sample types are suitable for the analysis of cell-free microRNAs. The microRNA abundance profile of bodily fluids reflects physiological and/or pathological conditions and, furthermore, does so more accurately than a messenger RNA (mRNA) abundance profile. While mRNA must be translated into protein to have a biological effect, microRNAs are themselves the active moieties, often influencing the expression of multiple other genes, and thus likely reflecting altered physiology more directly. Thus, the profiles of circulating microRNAs have been explored in a variety of studies aimed at the identification of novel non-invasive biomarkers. Overall, there is strong rationale for taking advantage of increasingly available sequencing modalities for blood-derived biomarker discovery. Several microRNA signatures that are unique to ovarian cancer have been proposed (Kinose et al 2014) and a set of highly abundant serum micro-RNAs has recently been found in patients with ovarian cancer, some of which were also deregulated in patients exhibiting normal CA-125 serum levels (Chen et al 2005) . It has also been found that microRNA signatures were different between ovarian carcinoma histotypes (serous, endometrioid, clear cell, and mucinous) (Iorio et al 2007 , Kinose et al 2014 . This data from biomedical publications indicates that circulating microRNAs might be good non-invasive markers, which could contribute to improving established clinical diagnostic tests at the early stage.
One of the main problems associated with extracting and analyzing circulating microRNAs is their quanti fication. Analysis of serum microRNAs by stemloop reverse transcription PCR (RT-PCR) has been widely used for sensitive detection of low abundant circulating microRNAs (Hou et al 2014) with high reproducibility. The extraction of cell-free microRNAs for their reliable detection and subsequent quantification using a TaqMan microRNA assay or other methods with amplification are, however, multi-step time consuming procedures. These methods are costly and typically yield terabytes of data requiring significant bioinformatics analysis capabilities. Thus, there is a crucial need for a screening test that is based on ubiquitous nucleic acid composition differences between normal and malignant cells, but is simple to perform and interpret (Buys et al 2011) . In addition, there is a pressing need for new tools, which can help identify the biology involved in cancer development and progression (Karst et al 2011) .
In this work we introduce a completely new THz spectroscopic technique and system having high spectral and spatial resolution (Globus et al 2013a) and demonstrate application of this technique for optical detection and analysis of ovarian cancer (OC) cell samples. We apply combined experimental and computational approaches to investigate the ability of sub-THz spectroscopy to identify biological molecules. Our initial study using this technique demonstrates spectroscopic signatures from ovarian cancer cells and cell free samples by interrogation of resonance features caused by atomic vibrations within biological molecules, which are absent in normal cells.
Ovarian cancer is used for this first demonstration; however the method is very general and can be as well applied to other cancer types.
Sub-THz vibrational spectroscopy technique for bio-identification
Recently, it has become clear that THz radiation could be extremely important for research related to the life sciences because of the unique capability of these low energy electromagnetic waves to interact with vibrations of atoms within biological molecules to produce specific molecular fingerprints (Globus et al 2006 (Globus et al , 2003a .
Sub-THz vibrational spectroscopy utilizes wavelengths beyond those traditionally used for chemical and biomolecular analysis. Biological materials are active in the frequency range of 0.05-1 THz and above (the submillimeter-wave range, ~1.5-30 cm −1 ). These frequency and wavelength domains, the spectral range between the upper end of the radio frequencies and the lowest optical frequencies were named the 'Terahertz Gap', because so little was known about them and because of the absence of radiation sources and detectors. Absorbance measurements in the THz region are just beginning to emerge as a new analytical technology.
Low energy THz radiation interacts with the lowfrequency internal molecular motions (vibrations) involving the weakest hydrogen bonds (H-bonds) and other weak connections within molecules by exciting these vibrations. Although hydrogen bonds are weak and have only ~5% of the strength of covalent bonds, multiple hydrogen bonds stabilize the structure of biopolymers, in particular holding the two strands of the DNA double helix together, or holding polypeptides together in different secondary structure conformations. The sub-THz regions of absorption spectra of bio-molecules and species reveal these low frequency molecular motions as resonances. The resonant frequencies of such motions, low energy vibrational modes, are strongly dependent on the 3D molecular structure. As such, these vibrational modes are sensitive to conformational changes of molecules and to environment. The sub-THz vibrational spectroscopy technique for identifying and characterizing objects is based on the specificity of spectroscopic signatures that reflects absorption of THz radiation at characteristic resonance frequencies.
H-bonds in biological macromolecules such as nucleic acids and proteins are important for their structure, biological interactions, and functions. Yet until recently there were no simple direct methods to observe and characterize H-bonds. Sub-THz vibrational spectroscopy of biological macromolecules directly targets hydrogen bonds, revealing resonance spectroscopic features, vibrational modes or groups of modes at close frequencies in absorption (transmission) spectra of biomaterials. The capability of sub-THz spectroscopy to detect directly low-frequency vibrations of weak bonds between different functional groups of atoms within biological molecules is unique, providing information quite different from visible or infrared spectroscopic characterization. Density of vibrational modes in the THz and especially in sub-THz regions is much lower compared to IR and far-IR, a fact that promises much higher discriminative capability of spectroscopy in this range. Indeed, THz signatures of large macromolecules are most specific to their sequence and 3D structure.
Instrumentation that works in this frequency region is very limited, thus not a lot of research has been performed in this area (Heilweil and Plusquellic 2007) . Until recently, Fourier transform (FT) transmis-sion spectroscopy (Bruker IFS66v) provided the most detailed information on sub-THz vibrational spectral signatures of biological molecules (Globus et al 2003a (Globus et al , 2006 (Globus et al , 2014a taken with a moderate spectral resolution of 0.25 cm −1 . However, the low THz power provided by traditional sources, like a mercury lamp, required a detector cooled with liquid helium for reliable characterization. The 12 mm optical aperture of this instrument dictated a large area sample with mg quantities of material. Measurements in air were possible since there are almost no absorption lines from water vapor or oxygen in the 10-25 cm −1 spectral range except water vapor absorption band around 18.6 cm −1 . However, a spectral resolution of 0.25 cm −1 does not provide the required specificity of spectral features to discriminate between individual molecules or bacterial strains.
A number of instruments that are based on time domain or photomixing technologies have recently been introduced for producing and measuring THz radiation, however most of them do not have the sensitivity, nor the spectral and spatial resolution required for biological molecules and cell characterization (Globus et al 2014a, Globus and Gelmont 2014) .
We have developed a new, frequency domain, nearfield spectroscopic instrument with imaging capability combined with a microchip for sample material that permits characterization of trace amounts of biological materials at room temperature (figure 1, Globus et al 2013a). This novel, continuous wave, frequency domain instrument is based on a very strong local enhancement of the electromagnetic field, thus allowing increased coupling of the THz radiation with the sample biomaterials.
Over the last 3 years, our new, sub-THz spectroscopic instrument was used to measure transmission/ absorption spectra from bio-molecules and cells and had already demonstrated very intense and narrow spectral features from biological molecules and cells with widths between 0.05 and 0.15 cm −1 (Globus et al 2013a , 2013b , 2013c , 2014b , Sizov et al 2013 that reflect low frequency molecular motions.
In parallel with experimental characterization, our group is developing computational modeling techniques to predict and study THz spectroscopic signatures of large macromolecules consisting of DNAs, RNAs, proteins and other molecular components of biological cells using energy minimization, normal mode analysis and molecular dynamics (MD) approaches (Bykhovskaia et al 2001 , Globus et al 2002 , 2003a , 2003b , 2013b , 2014b , Alijabbari et al 2012 , Sizov et al 2013 . Combining simulations with experimental techniques improves analysis and understanding of measured spectra and even provides predictive capabilities for modeling.
We have found that experimental spectra from biomolecules correlate reasonably well with computational predictions, that the spectra from different cells are sufficiently different, and that cells can be identified based on their spectral signature. Since biological cells are so small, sub-THz radiation propagates through the entire cell and reveals spectroscopic information from molecular components inside the cell , 2013a , 2014a , Globus and Gelmont 2014 . Our previous computational modeling results confirmed that observed spectroscopic features from bacterial cells are due to the fundamental physical mechanism of interaction between THz radiation and biological macro-molecules inside the cell (Sizov et al 2013 , Globus et al 2013b , 2013c , 2014b . In particular, the analysis of results indicates that the spectroscopic signatures of microorganisms originate from the combination of low-frequency vibrational modes or groups of modes at close frequencies (vibrational bands) within molecular components of the cells (Globus et al 2013b) . These features were not evident in previous results obtained with a resolution of 0.25 cm −1 . Multiple intense and specific resonance features provide a condition for reliable discriminative capability using sub-THz frequency domain spectroscopy, to the level of strains of the same bacteria that was not possible before.
THz vibrational spectroscopy can be used for fast characterization and fingerprinting of biological molecules and organisms with limited quantities of sample materials. Since well-resolved THz spectra from biological molecules are specific to their sequence and 3D structure and can be used for the fast characterization and fingerprinting of biomolecules, this method has a potential to improve the way diagnosis of early stages of some types of cancer is conducted, offering a new optical, non-dangerous, low-cost and fast THz analysis that is complementary to other analyses for determining the type of cancer cells present.
Materials and methods

Cell samples
Two human ovarian cancer cell lines, SKOV3 (ATCC ® HTB-77 ™ ) and ES-2 (ATCC ® CRL-1978 ™ ), were obtained from a vendor that verifies their identity using genomic fingerprinting (American Type Culture Collection).
Most ovarian cancer research is based on the hypothesis that high-grade serous ovarian carcinoma (HGSOC) arises from ovarian surface epithelial cells. However resent studies suggest that >50% of this lethal disease likely arise from fallopian tube epithelium (Karst et al 2011) . Consequently, a short term human fallopian tube epithelial cell line (FT131) was established as previously described (Jazaeri et al 2013) as a normal control, for comparison with the sub-THz signatures of the ovarian cancer cells. All cell lines were grown in McCoy's 5A media supplemented with 10% FBS. Cells were grown to confluence, trypsinized and fixed in 70% ethanol, then stored frozen until analyzed. Cancer cell solutions were prepared at concentrations of 150 and 300 cells µl −1 , and normal cells were prepared at 100 cells µl −1 and 50 cells µl −1 concentration.
Sub-THz spectroscopy measurements procedure
The procedure for sub-THz spectroscopy measurements is described in detail in our previous papers (Globus et al 2013a , 2013b , Sizov et al 2013 . Metal microchannel arrays were fabricated from gold (3 µm thick on polymethyl methacrylate, PMMA) or copper (5 µm thick on polyimide), with 10 µm wide channels through the metal on 150 µm centers, to serve as sample holders. A sample holder was installed into the THz spectrometer (figure 1), and background frequency scans were performed at multiple locations on the array over the frequency range of the instrument (310 GHz-490 GHz). A dilute solution (suspension) of a sample was then micropipetted onto a small spot (~1 mm 2 ) on the array where background scans had been performed, and allowed to dry, normally for ~10 min. Based on the size of the channels in the array and the detector opening width, ~200 µm, a volume of roughly 10 pl is interrogated in each spectroscopic measurement. Once the sample had been applied, the detection probe was repositioned at a location previously interrogated, and the sample was scanned. Most of the measurements performed were where the cancer cell suspension samples had been applied but no cell was observed to be present. Since the probability of a cell being in the channel under the probe (~50 µm length) is very small (less than 10% in all the channels in the entire spot) and all precautions were made to not disrupt the cells, we expect that the measurements represent cell free sample spectra. Cell characterization was performed in one occasion when a cell was observed inside the channel in a location that had been previously interrogated to obtain a background spectrum. Sample transmission (T) was calculated as the ratio of the signal spectrum (with material) to the background spectrum. Because background and sample scans are performed at each position to calculate transmission, the transmission results are independent of position and can be compared at different positions and between samples on different sample holders. Transmission was then recalculated for absorbance A in relative units using A = −log(T ) for analysis of scaling results depending on the amount of sample material deposited, and for further comparison with the computational modeling results.
The choice of concentration and the amount of sample material are important. As the sample holder arrays are fabricated on thin plastic substrates, too much sample introduces curvature to the substrate, significantly modifying the radiation path during sample versus background measurements, resulting in artifacts that revealed as calculated transmission above 1. These results are not included in the analyses and required reductions in the amount of material used for measurements. An optimal concentration of cancer cell in the sample material below 300 cells µl −1 was determined from these experiments with a sample volume of ~0.1-0.5 µl, since these are enough to produce a thickness after drying to receive accurate and reproducible results with rather narrow spectral features, whereas a thicker dried layer lead to widening line widths due to overlapping neighboring spectral lines.
Each sample was interrogated multiple times at multiple positions on a sample holder array and at different times to demonstrate consistent spectral features, to eliminate possible artifacts and to characterize the reproducibility and sensitivity of the measurements. The reproducibility of the transmission and absorption measurements is sensitive to accurate positioning of the microdetector probe in the background and sample measurements. Standard deviation values and errors for transmission have maximum values (up to 10%) at the two ends of the instrument spectral range, and at frequencies with minimum background intensities. Reproducibility of the position of spectral features on the frequency scale is good, however, better than 0.05-0.1 cm −1 .
Results
Ovarian carcinomas comprise a heterogeneous group of neoplasms (McCluggage 2011), and there are four (McCluggage 2011) or five (Muralidhar and Barbolina 2015) most common epithelial ovarian cancer (EOC) subtypes, which are high grade serous, low grade serous, endometrial, clear cell, and mucinous (Bast et al 2009) . Each of these histotypes has been found to be associated with mutations in specific genes and have different clinical manifestations (Köbel et al 2008) . It is also firmly established now that there are two distinct types of ovarian serous carcinoma, low grade and high grade, and both are usually advanced stage (stage III or IV) at diagnosis. SK-OV-3 and ES-2 are cell lines representing two epithelial histotypes. SK-OV-3 human epithelial, high grade serous carcinoma (our short notation is S-line), and ES-2 human clear cell carcinoma (our E-line), both in advanced stage (stage III or IV) at diagnosis, are the most common subtypes of ovarian carcinoma that arise from the epithelium. ES-2 human clear cell carcinomas typically present as low grade neoplasms (Concin et al 2003 , McCluggage 2011 , Nowak-Markwitz and Spaczynski 2012 . As a normal cell control, the FT131 cells from fallopian tubes were selected, since recent evidence suggests that >50% of high grade serous carcinomas in the ovary likely arise from fallopian tube epithelium tissue (Karst et al 2011) . Table 1 lists the cancer and reference samples that were characterized.
Since these are two ovarian cancer cell lines representing two different subtypes, we expected to see differences in their spectra. We also expect similarities for each of the cell lines at different cell concentrations. Figure 2 (a) illustrates the spectral features in the transmission calculated for one scan of an S-line cancer cell sample with three different background measurements. The observed variations are mainly due to small mismatches of the probe position (less than 1 µm) relative to the channel during the background and sample scanning. The positions of transmission sharp minima, which correspond to absorption peaks, are, however, reproduced with accuracy better than 0.1 cm −1 . Absorption frequencies are the most important spectral features, and the major peak occurred at 12.95 ± 0.05 cm −1 for this sample. Even for smaller peaks, the reproducibility is quite good in most cases. The intensities of lines are less important, although they generate the spectral pattern that will be used for signature analysis. The central peak in the S-line sample shows multiple local minima, suggesting that this central feature is actually a combination of several peaks at close frequencies. Figure 2(b) shows results for an E-line cancer cell sample, with sample and background measurements collected at three different positions along a channel. Once again, the frequencies of the transmission minima are reproduced almost with the same accuracy. The intensity of the absorption at each position is different, which can be explained by the different amounts of material dried at each position along the channel.
Comparison of the spectra in figures 2(a) and (b) for OC S-and E-lines demonstrate that the most intense transmission minimum, corresponding to an absorption peak, is observed at the same frequency, 12.95 cm −1 . S-line and E-line samples have been measured in different sample microchips, and in each case background has been measured (see section 3). At the same time there are definitely specific differences in spectroscopic features aside from the central peak, the most prominent are unique transmission minima at 14 cm −1 and 16 cm −1 in the spectra of E-line samples.
To facilitate the comparison of results from different samples for data quantification, transmission spectra were recalculated for absorbance and the spectra were normalized to the same absorbance at the peak value around 13 cm −1 . When cell line samples were applied on the chip for measurements, the cells did not cover the entire area that was to be interrogated, thus spectral measurements were performed when a cell was present under the probe, when no cell was present (cell free-c.f.), and when cell fragments were present near the probe. Figure 3 compares the absorbance of S-line samples in cancer cell, cell free (c.f.) and cell fragment regions, all showed essentially the same spectra. It is clear that the central frequency of the main absorption peak is reproduced with high accuracy of better than 0.1 cm −1 . Figure 4 again demonstrates the similarity of absorbance features near the peak at ~13 cm −1 between the two cancer sample lines, S and E. One curve (E-line) is upshifted, showing better the THz absorption signatures differences. A second, rather significant absorption peak in the spectral range occurs at the frequency 11.4 cm −1 . Additional spectral features presented in the E-line spectra near the frequencies 12.2, 13.9 and 16 cm −1 require further confirmation. Figure 5 compares absorption spectra of S-line OC samples with two concentrations of cells: 300 and 150 cells µl −1 . The peak at ~13 cm −1 dominates in both spectra. As we observed in many cases, samples with less amount of material very often show more narrow spectral lines. The spectroscopic signature from cancer samples is very stable and reproduces experimental results of early measurements conducted in a time interval of more than 2 years.
It is more difficult to characterize absorbance of normal cells because the spectroscopic signature is significantly weaker than that of cancer cells. Figure 6 presents averaged results for absorbance from two normal cell samples normalized to the same concentration of 300 cells µl −1 for convenience of comparison with cancer cell samples. Multiple absorption resonances are observed over the entire spectral range of our instrument reflecting the complex molecular content of normal cells. The pattern of the normal cell (NC) spectra seems more similar to experimental and simulated spectra of genetic nucleic acid molecules presented in our previous publications (Globus et al 2013b (Globus et al , 2013c .
The result shown in figure 6 is the first and important demonstration of the sub-THz spectroscopic signature from fallopian tube epithelium cells. If these cells may indeed be the origin for high grade serous ovarian carcinoma, the modification of this signature might become the first sign of ovarian cancer at the initial step of disease development that can be used for early cancer detection and diagnosis. Figures 7(a) and (b) compare directly the absorbance of the ovarian cancer S-line and E-line cells with normalized spectra of normal cells. Beyond the central peak at ~13 cm −1 attributed to OC, there is some similarity between the CC and NC that seems slightly more correlated for the S-line at frequencies 10.5 cm −1 , 10.9 cm −1 , 14.3 cm −1 , and 15.7 cm −1 , while for E-line at frequencies 12.2 cm −1 and 15.9-16.2 cm −1 . However, these portions of the spectra do not necessary have to correlate, as different molecules, contributing to absorption in this region, are expected to be present in the different cell types.
Molecular dynamics simulations
We observe a dramatic difference between the THz absorption spectra of cancer and normal cells with much higher intensity and a very strong peak at frequency ~13 cm −1 , which dominates the spectra from cancer samples in the spectral range of our instrument. Neither DNA nor protein molecules that we characterized up to now (Globus et al 2013a (Globus et al , 2013b (Globus et al , 2013c have spectral transmission/absorption patterns near 13 cm −1 that correlate with the experimental results from cancer cells demonstrated in figures 2-5 and 7(a) and (b). At the same time results from the medical literature discussed in section 6 suggested to us that one potential source of this strong and specific spectral feature in cancer samples might be short double stranded molecules of matured microRNAs. Experimental measurements of extracted microRNA and synthetic microRNA were beyond the scope of this study and are planned for future work, but in this work we wanted to obtain initial confirmation that microRNA could be the source of the strong spectral peak.
In order to verify whether the contribution from microRNAs might help explain the observed cancer signature, we conducted molecular dynamics simulation to predict the sub-THz absorption signatures from specific microRNAs that were studied in the literature and were shown to be the most overexpressed and important in ovarian cancer. The high overexpression level of microRNA-200 family and the involvement of these molecules in epithelial OC as well as other cancers were determined in many studies as shown in a recent review (Muralidhar and Barbolina 2015) . The microRNA-200 -200a, miR-200b, miR-200c, and miR-141 . The sequences of these microRNAs found in www.mirbase.org are shown in table 2 using entries in the database as indicated.
In normal cells microRNA regulates formation of messenger RNA (mRNA). The short noncoding regulatory RNAs are derived from regions of RNA transcripts that fold back on themselves to form short hairpins. In the maturation process, the single strands of microR-NAs find complimentary part of mRNAs. During posttranslational regulation the hairpin is cleaved, which is followed by formation of an imperfect microRNA duplex about 22 nucleotides in length (Lund and Dahlberg 2006) . Mismatch defects in this duplex occur when the complementary pair could not be created. Thus, during maturation, microRNA forms a duplex, whose 3D structure can be reconstructed using a molecular dynamics software such as MacroMoleculeBuilder and Assemble2. 2D illustrations showing imperfect structures of the microRNA molecules for simulation without loop but with mismatches are presented in figures 8(A)-(D) . For miR-141 we simulated two different molecules: the ideal sequence shown in the table 2, and the matured imperfect microRNA with mismatches as shown in figure 8(D) with one of the goals to verify if mismatches are important contributers to absorption in this frequency range.
Molecular dynamics protocol and absorption coefficient calculation are described in our previous work (Alijabbari et al 2012) . Initial atomic coordinates of microRNAs are found using data available in the mirbase.org database in a Vienna format. The data was downloaded into Assemble2 software (Jossinet and Westhof 2014) , where atomic coordinates were then restored for the chain that has a 3′5′ direction and the complimentary chain in 5′3′ direction.
We modeled microRNA molecules in water. The empirically parameterized molecular mechanics force field ff14SB (Duan et al 2003) and the water model TIP3P (Jorgensen et al 1983) were used. The molecule was solvated with a 12 Ǻ shell of water and the charge was neutralized by adding Na+ ions. In all MD simulations, the hydrogen bonds on water molecules are kept fixed. In preparation steps, a constant volume and temper ature (NVT) ensemble is used to raise the temperature to 293 K. The system is heated for ~16 ps, and atoms are restrained using a 10 kcal/mol/Å 2 force constant. During this heating process, bonds involving hydrogen are fixed. Constant pressure periodic boundary conditions are used to scale the system volume during 100 ps to reach a density of ~1 g cm −3 . In these procedures, a 10 Å real space cutoff is used with a 2 fs integration time step. Once the system has reached target temperature and equilibrium density, random velocities from the Maxwellian distribution are assigned to all atoms, followed by another equilibration step (NPT ensemble) for further system stabilization. After equilibration, a 600 ps production run is performed in a constant volume and energy ensemble (NVE) to avoid undesirable effects on atomic motions due to coupling to an external thermal bath. During the simulation, the coordinates of all atoms of the system are recorded every 20 fs for the entire production run. Quasi-harmonic analysis was used to obtain atomic displacements for different modes of vibrations from atomic trajectories. Better simulation convergence and improved consistency between simulated vibrational frequencies and experimental data were obtained using a procedure for averaging mass-weighted covariance matrices of atomic trajectories in MD simulations (Alijabbari et al 2012) . Averaging of just six matrices gives more consistent results. Comparison of two spectra calculated using a covariance matrix from an entire production run and from an averaged covariance matrix is useful to estimate overall stability of molecular dynamics. The absorption spectra were calculated from the atomic displacements as in our previous work (Bykhovskaia et al 2001 , Alijabbari et al 2012 with the line broadening parameter equal to 0.12 cm −1 .
For the mature form of miR-141, which contains mismatches described in the miRBase database (http:// mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000457) and shown in figure 8(D) , the absorption line shape was found from the calculated dipole moment history of the system by converting dipole correlations into the power spectrum (Ladouceur et al 1989) . This was done to account for large-amplitude motions of mismatched terminal GGA3 residues schematically shown at the bottom right in figure 8(D) , which would be impossible to do within the quasi-harmonic approximation.
Sub-THz absorption spectra calculated using MD simulation for four members of the miR-200 family, including miR-141 are presented in figures 9 and 10. Spectra from three of these four molecules (miR-200a, miR-200c and miR-141) show a significant absorption peak at 13 cm −1 observed in experiments along with additional absorption peaks at other frequencies. As expected, the spectra from each of these individual microRNAs are unique. From these four spectra, the results for miR-200c, and especially for miR-141 (see the section 6) correlate better with experimental data for both cancer lines. Figure 10 shows the simulated spectra of both, the ideal and the matured versions of miR-141. The presence of the mismatches in the matured version clearly contributes to the absorption peak at 13 cm −1 and to the entire spectrum. It appears that unpaired residues influence absorption line intensities (miR-200c and miR-141) . A new simulation protocol applied to miR-141 with defects resulted in observing much higher density of absorption peaks in model spectrum of this mature micro RNA molecule. In the following section 6 we demonstrate that modeling miR-141 with mismatches not only predicts the central peak at ~ 13 cm −1 , but points to a presence of a band consisting of several peaks close on the frequency scale, which is also observed in our experimental OC spectra (figures 3 and 4) . The simulation reproduces the fine structure of this band (up to 10 individual peaks) with the accuracy within 0.3% on the frequency scale.
Discussion
In cancer cells microRNAs become deregulated showing increased concentration in blood, serum and tissue cells (Lu et al 2005 , Mitchell et al 2008 . Since microRNAs modulate the expression of critical genes and the signaling networks involved in tumorigenesis, there is mounting evidence that microRNAs are involved in cancer development (Parikh et al 2014 and references 3 and 4 within) . According to experimental studies, microRNAs can be overexpressed by 50-600 times during cancer progression (Wyman et al 2009 , Pereira et al 2010 , Granados López and López 2014 . MicroRNAs are present in ovarian cancer (OC) cell-free bodily fluids, and these molecules are the major fraction of small nucleotide species in serum (Lu et al 2005) . MicroRNAs in serum are sufficiently stable to serve as clinical biomarkers, serum microRNA profiles reflect physiological conditions, and circulating microRNAs are correlated with tumor progression (Gilad et al 2008 , Brase et al 2010 . All these facts explain why we looked at microRNA absorbance to understand the difference in sub-THz absorption spectra of cancer and normal cell samples observed in our measurements.
The choice of specific microRNA for analysis of spectroscopic signatures is also important since the human genome encodes ~550 microRNA genes to express about 1000 microRNAs (Wang et al 2014) . However, these microRNAs are found to be differentially expressed in various human cancer cell types (Landgraf et al 2007) . For example it was shown that only 4 of 29 microRNAs studied by Iorio et al (2007), miR-141, miR-200a, miR-200b, and miR-200c, were upregulated. The microRNA-200 family among other microRNAs has ~50-100 times overexpression level in endometroid ovarian cancer compared to normal primary human ovarian surface epithelium (HOSE) cultures (Landgraf et al 2007 , Wyman et al 2009 . A recent analysis of data from the Cancer Genome Atlas (TCGA) (Landgraf et al 2007) identified a gene network along with the predicted regulatory microRNAs that characterized a phenotype of serous epithelial ovarian cancer (EOC) (Muralidhar and Barbolina 2015) . They showed that 89% of the target genes in the network were regulated by 8 key microRNAs. Two of these key microRNAs, miR-141 and miR-200a, are members of the microRNA-200 family.
The high overexpression level of the microRNA-200 family was also determined in other studies as shown in a recent review (Muralidhar and Barbolina 2015) : the microRNA-200 family has repeatedly been implicated for its involvement in EOC as well as other cancers (Gadducci et al 2014 , Humphries and Yang 2015 , Muralidhar and Barbolina 2015 , Zaravinos 2015 . In addition, microRNA signatures are different between ovarian carcinoma histotypes (serous, endometrioid, clear cell, and mucinous) (Iorio et al 2007 , Kinose et al 2014 , which could account for some differences we observed in the experimental spectra of the S and E line cells.
The involvement of the microRNA-200 family (miR-200a, 200b, 200c, miR-141) in epithelial OC as well as other cancers was determined in many studies (Muralidhar and Barbolina 2015) . The major finding is upregulation of showed increased expression in serous, endometrioid and clear cell cancer while miR-200b and miR-141 were upregulated in endometrioid and serous histotypes thereby indicating histotype specificity (Muralidhar and Barbolina 2015) . In a different work it was found that only miR-200c and miR-141 were up-regulated in high grade serous tumors (Lee et al 2009) .
Expression levels of serum microRNAs are reproducible and consistent among individuals. At the same time, many regulating proteins, which experience upfold change during cancer development and thus can be considered as potential contributors to absorption difference between cancer and normal cells, are found to have overexpression level of only 5-10 times (Szostek et al 2014) .
We have previously demonstrated that short DNA duplexes have strong specific symmetry vibrational resonances in sub-THz frequency range (Globus et al 2003a , 2013b , Sizov et al 2013 . It was shown that the internal low-frequency motions correspond to helical twisting, bending, and stretching, as well as sugar pseudo rotational vibrations. These motions and absorption spectra are affected by DNA length, nucleotide composition, and topology (A-, B-or Z-form) (Duong and Zakrzewska 1997) . These strong spectral features can explain the central spectral peaks presented in figures 5-9. The rest of the cancer signature shown in these figures is in part similar to the signatures of normal cells and might also represent contributions from proteins and nucleic acid polymer molecules.
It was reported (Iorio et al 2007) that both, miR-200a and miR-200c showed increased expression in serous, endometrioid and clear cell cancer. The S line of cancer cells (SKOV3) represents a high grade serous type tumor, and the E-line cells (ES2) represent a clear cell carcinoma. For this reason we compare in figures 11 and 12 the experimental absorbance spectra from an E-line and from S-line cancer samples, corre spondingly, with the simulated signatures from mixtures of miR-200a and miR-200c. While the simulation from neither of these individual microRNAs had the largest peak at 13 cm −1 , the additive effects of the simulated mixture at this frequency makes this peak stand out above other peaks in the spectra.
Correlations of many features in the simulated mixture and the experimental spectra of both lines shown in figures 11 and 12 are obvious. The closest matching is, however, demonstrated in figures 13 and 14 that compare measured spectra of OC S-and E-lines with simulation results for mature miR-141. Both measured and simulated spectra reveal a similar fine structure of the 13 cm −1 band with individual peaks coinciding within the 0.05 cm −1 accuracy. For the E-line, the positions of almost all 9 peaks of this band are reproduced (see figure 14) .
According to our simulation results, the 13 cm −1 band appears when there is considerable mismatch at one end of the microRNA. Indeed, the only model structure lacking this band is miR-200b, which is completely defect-free at the ends, with 6 base pairs at one end and 4 at the other (see figures 8-10). Assuming that overexpressed microRNAs dominate in absorption around 13 cm −1 (which will have to be ultimately verified by direct measurements), we conclude that the fine structure around the central peak at ~13 cm −1 revealed in experimental results for both S-and E-lines (figures 3, 4, 11-red and 12-blue) might be attributable to the base mismatches near the end of the microRNA molecule.
In addition to the presence of other microRNAs and other overexpressed biomolecules, there are other possible reasons for the partial disagreement between experimental and simulated spectra. In particular, since there is currently no understanding of what the 3D structure of microRNAs actually is when they are released from the cells, such as in exosomes containing these circulating molecules in blood (Brase et al 2010) , the simulation represents only our best understanding of the microRNA structures at this point.
In this work we present the very first study on the results for spectroscopic signatures from cell lines representing endometrial ovarian cancer in the sub-THz frequency range. It is already easy to observe major differences between cancer and normal samples in this spectral range that might allow for use of this method as a new cancer analysis technique. The presence of peaks near 13 cm −1 in the simulated spectra of overexpressed microRNAs provide evidence that these molecules might be contributing to the unique peak observed in the cancer cell spectra. This evidence warrants further experimental measurements using extracted or synthetic microRNA to confirm the simulations results for microRNA and to help fully define the source of the strong spectral peak in the cancer cell samples. Correlation of the signature change with tumor progression needs to be studied, and a more thorough invest igation and detailed analysis are needed to understand the observed variability of absorption peak intensities.
Conclusions
The application of sub-THz absorption/transmission technology for early cancer diagnostic and prognosis should be possible and simpler than current methods. Since THz radiation detects signatures from components inside the cancer cells, the complicated procedures of extracting biomarkers from the cells would not be necessary and could be eliminated. This spectroscopic method provides the opportunity to look for specific spectral signatures from molecules within each cell, to differentiate between cell types, or to look at influences of environmental factors on cellular function, representing new analytical research capabilities not provided by current instrumentation. The new technology would be applicable for laboratory testing of unique spectroscopic signatures from markers like DNA, RNA, and protein biomarkers, or from entire cells in specimens from core or fine-needle aspiration biopsies from most types of cancer. Spectroscopic evaluation of potential molecular markers in saliva or blood (for example, circulating short RNA molecules) could also be possible, but the diversity of proteins, cells, and nucleic acids in blood would complicate the analysis. Because THz spectroscopy is non-destructive, it can be used in conjunction with standard molecular biology techniques. The new technology could significantly assist qPCR methods by providing quick preliminary data and making DNA and RNA analysis a more effective and targeted procedure. Figure 13 . Measured absorbance of S-line cancer sample (yellow circles), versus simulated spectrum for miR-141 with mismatches (solid blue line). Both spectra reveal a similar fine structure of the 13 cm −1 band with the accuracy of most absorption peak positions within 0.05 cm −1 . Figure 14 . Fine structure of absorption peak at ~13 cm −1 revealed in measured spectra from OC E-line (green line with circles) and in model of miR-141 with defects (solid red line). Almost all 9 peaks are reproduced within 0.05 cm −1 .
